Companies › TIL
Instil Bio Inc (TIL)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001789769 · EDGAR filings · Updated 2026-06-12
Instil Bio Inc (TIL) has reported institutional ownership of 33.2%, with 31 institutional managers holding positions valued at $18.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-11 — Current report (8-K) filed
- 2026-05-15 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Instil Bio Inc has 31 institutional holders and institutional ownership of 33.2%.
Insider activity
Insiders reported 4 transactions (0 buys, 2 sells) across 1 reporting insiders, with a net reported value of −$701.7K.
Data flags from SEC filings
Related companies
Neonc Technologies HLDGS (NTHI) · Grace Therapeutics Inc (GRCE) · PELTHOS THERAPEUTICS INC (PTHS) · AURORA CANNABIS INC NO PAR (ACB) · POLARYX THERAPEUTICS INC (PLYX) · TUHURA BIOSCIENCES INC (HURA)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-12.